Predictive health intelligence & data analytics provider

Airfinity is a pioneer in predictive health analytics that helps decision makers to understand and act on to pre-empt future health risks.

Specialising in infectious diseases, Airfinity has a comprehensive suite of world-leading market intelligence solutions, turning disconnected data points into real time predictive indicators. The platform alsocovers advanced therapies (e.g. RNA, Gene and Cell Therapy) and cardio-metabolic.

Disease-centric solutions combine proprietary surveillance tools and forecast models with expert analysis to produce actionable insights on pipeline developments, standard of care, regulatory trends and demand and supply.

Airfinity is a global company with headquarters in London and Boston, relied upon across the full ecosystem in life sciences, including pharma companies, government agencies, corporates, investors, NGOs, and international organisations.

Our initial £1.4mn investment was completed in 2021.

We topped up our investment by £0.6mn in September 2023.

Our investments have helped to further strengthen the senior leadership and product teams.

Investment rationale

The business’ core proposition helps solve a key problem by collating and aggregating vast, disparate data sets to provide easily accessible/searchable data in order to facilitate decision-making. It supports our focus on how the proliferation of vast datasets are being poorly accessed by the life sciences community and how platforms/tools can be used to better make use of internal and external data sources to accelerate drug development.

The business has scaled rapidly led by a very able founder and CEO.

Investment team

Maya Ward

Investment Director

Maya joined Gresham House in September 2019, and focuses on healthcare investments, including Orri, Metrion Biosciences and Panthera Biopartners.

Prior to Gresham House, she spent 4 years at Octopus Investments, investing in real estate-backed healthcare companies and entrepreneurs. Before this she worked at KPMG for 7 years in audit and corporate finance.

Maya holds a first-class degree in Modern History and is a Chartered Accountant (ICAEW).

Outside of work, Maya enjoys playing hockey (when not suffering from an injury!), travelling and watching martial arts films.

It’s a pleasure to be investing in the future of UK healthcare across a range of sub sectors and working with some of the country’s top scientists and clinicians to deliver world-class solutions.

Example portfolio

orri logo orange

Brendan Gulston

Director, Public Equity

Brendan joined Gresham House in November 2018 having previously been at Livingbridge and is an integral part of our Public Equity team, as co-fund manager of the LF Gresham House UK Multi Cap Income Fund.

I love finding businesses where you can drive conviction early on, conclude a successful investment and continue to support them along the journey.

Brendan studied commerce with a focus on finance and subsequently spent four and a half years in technology investment banking at Canaccord Genuity.

Outside of work he enjoys skiing and is a big fan of the alpine lifestyle, as well as exploring new places, various creative pursuits and playing sport.

Example portfolio

Privacy Preference Center